Clinical impact of 68Ga-DOTATATE PET-CT imaging in patients with medullary thyroid cancer.
Murat TuncelSaadettin KılıçkapNilda SüslüPublished in: Annals of nuclear medicine (2020)
68 Ga-DOTATATE is an essential part of the work-up for patients with MTC. This modality outperformed CI in 14/38 (37%) patients and changed the clinical management in 13/38 (34%) patients. Prospective randomized studies with image-guided therapy decisions are needed to further reveal the impact of PET imaging in patients with MTC.